Laura Lee Sandler, COO of Oruka Therapeutics ($ORKA), made five open market sales of company shares over the past year, totaling about $539,000. Her latest sale occurred on March 2, 2026. Among nearly 12,000 insiders with recent sales, her activity ranks 6,274th by value, well below the average of $8.6 million across 6.4 transactions per person. She recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | S | Common Stock | 600 | $41.30 | 236,984.0000 | 42,095,951 | 0.25% | 0.00% |
| March 2, 2026 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | M | Employee Warrant (right to buy) | 5000 | $0.00 | 89,996.0000 | 42,095,951 | 5.26% | 0.01% |
| March 2, 2026 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | M | Common Stock | 5000 | $7.80 | 242,584.0000 | 42,095,951 | 2.10% | 0.01% |
| March 2, 2026 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | S | Common Stock | 2325 | $33.28 | 240,259.0000 | 42,095,951 | 0.96% | 0.01% |
| March 2, 2026 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | S | Common Stock | 2675 | $33.81 | 237,584.0000 | 42,095,951 | 1.11% | 0.01% |
| Jan. 23, 2026 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | A | Common Stock | 32500 | $0.00 | 237,584.0000 | 42,095,951 | 15.85% | 0.08% |
| Jan. 23, 2026 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | A | Employee Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 42,095,951 | 9999.99% | 0.31% |
| Jan. 2, 2026 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | S | Common Stock | 1108 | $29.75 | 205,084.0000 | 42,095,951 | 0.54% | 0.00% |
| Jan. 2, 2026 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | M | Employee Warrant (right to buy) | 5000 | $0.00 | 94,996.0000 | 42,095,951 | 5.00% | 0.01% |
| Jan. 2, 2026 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | S | Common Stock | 3144 | $29.08 | 206,192.0000 | 42,095,951 | 1.50% | 0.01% |
| Jan. 2, 2026 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | M | Common Stock | 5000 | $7.80 | 218,084.0000 | 42,095,951 | 2.35% | 0.01% |
| Jan. 2, 2026 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | S | Common Stock | 8748 | $28.17 | 209,336.0000 | 42,095,951 | 4.01% | 0.02% |
| July 1, 2025 | Oruka Therapeutics, Inc. | $ORKA | Sandler Laura Lee | Chief Operating Officer | A | Employee Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 42,095,951 | 9999.99% | 0.06% |